Last reviewed · How we verify
Chlamydia Cervicitis
Approved treatments
- Azo Gantrisin · Alra
- E-Mycin · Generic (originally Abbott/Lilly)
- ALATROFLOXACIN · Pfizer
- Zithromax · Pfizer Inc.
Macrolide antibiotic that binds the 50S ribosomal subunit, inhibiting bacterial protein synthesis with an exceptionally long tissue half-life. - Tomefloxacin · Otsuka
- Benzamycin · Pfizer
- Noroxin
- Floxin
- Ofloxacine · Assistance Publique - Hôpitaux de Paris
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Chlamydia Cervicitis patent landscape — cliff calendar, originator estates, attackable patents
- Chlamydia Cervicitis treatment landscape brief
- Chlamydia Cervicitis treatment updates RSS
Frequently asked questions about Chlamydia Cervicitis
What drugs treat Chlamydia Cervicitis?
Tracked treatments include Azo Gantrisin, E-Mycin, ALATROFLOXACIN, Zithromax, Tomefloxacin, Benzamycin, Noroxin, Floxin.
What is the treatment for Chlamydia Cervicitis?
Standard treatment for Chlamydia Cervicitis includes Azo Gantrisin, E-Mycin, ALATROFLOXACIN, Zithromax, Tomefloxacin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Chlamydia Cervicitis patent cliff · Chlamydia Cervicitis CI report
- Treatment: Azo Gantrisin · Alra
- Treatment: E-Mycin · Generic (originally Abbott/Lilly)
- Treatment: ALATROFLOXACIN · Pfizer
- Treatment: Zithromax · Pfizer Inc.
- Treatment: Tomefloxacin · Otsuka
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing